摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-乙基苯基)-3-氧代丁酰胺 | 32357-75-8

中文名称
N-(4-乙基苯基)-3-氧代丁酰胺
中文别名
——
英文名称
3-oxo-N-(4'-ethylphenyl)butanamide
英文别名
4'-ethylacetoacetanilide;N-(4-ethylphenyl)-3-oxobutanamide
N-(4-乙基苯基)-3-氧代丁酰胺化学式
CAS
32357-75-8
化学式
C12H15NO2
mdl
MFCD00600403
分子量
205.257
InChiKey
YSUAIVVYFQPYAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    390.2±35.0 °C(Predicted)
  • 密度:
    1.106±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    46.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2924299090

SDS

SDS:e15860c1f0ea845d95574601f2ddb28b
查看

反应信息

  • 作为反应物:
    描述:
    N-(4-乙基苯基)-3-氧代丁酰胺硫酸 作用下, 以 甲醇 为溶剂, 以66%的产率得到6-乙基-4-甲基喹啉-2(1H)-酮
    参考文献:
    名称:
    Compounds for the treatment of pain
    摘要:
    这项发明提供了治疗疼痛、尿失禁和其他由NPFF受体介导的异常的方法,包括向受试者施用在NPFF1受体、NPFF2受体或同时在NPFF1和NPFF2受体上起作用的化学化合物的治疗有效量。
    公开号:
    US20030176314A1
  • 作为产物:
    描述:
    双乙烯酮4-乙基苯胺三乙胺 作用下, 以 为溶剂, 以90%的产率得到N-(4-乙基苯基)-3-氧代丁酰胺
    参考文献:
    名称:
    Inhibitors of Tick-Borne Flavivirus Reproduction from Structure-Based Virtual Screening
    摘要:
    Flaviviruses form a large family of enveloped viruses affecting millions of people over the world. To date, no specific therapy was suggested for the infected people, making the treatment exclusively symptomatic. Several attempts were performed earlier for the design of fusion inhibitors for mosquito-borne flaviviruses, whereas for the tick-borne flaviviruses such design had not been performed. We have constructed homology models of envelope glycoproteins of tick-transmitted flaviviruses with the detergent binding pocket in the open state. Molecular docking of substituted 1,4-dihydropyridines and pyrido[2,1-b][1,3,5]-thiadiazines was made against these models, and 89 hits were selected for the in vitro experimental evaluation. Seventeen compounds showed significant inhibition against tick-borne encephalitis virus, Powassan virus, or Omsk hemorrhagic fever virus in the 50% plaque reduction test in PEK. cells. These compounds identified through rational design are the first ones possessing reproduction inhibition activity against tick-borne flaviviruses.
    DOI:
    10.1021/ml400226s
点击查看最新优质反应信息

文献信息

  • Ni(0)–Cu(<scp>i</scp>): a powerful combo catalyst for simultaneous coupling and cleavage of the C–N bond with cyclization to valuable amide-based pyrroles and 4-pyridones
    作者:Dipanwita Roy、Satinath Sarkar、Radha M. Laha、Nabyendu Pramanik、Dilip K. Maiti
    DOI:10.1039/c5ra12115a
    日期:——

    We demonstrate unprecedented Ni(0)–Cu(i) combo catalysis for sequential bond activated domino N–C/C–C coupled annulation with N–C bond cleavage to afford valuable amide-based polysubstituted pyrroles and 4-pyridones selectively from β-ketoanilides.

    我们展示了前所未有的Ni(0)–Cu(i)组合催化剂,用于顺序键活化的多米诺N–C/C–C偶联环化反应,通过N–C键裂解从β-酮基苯胺中选择性地得到有价值的酰胺基多取代吡咯和4-吡啶酮。
  • Water – the best solvent for DMAP-mediated dual cyclization towards metal-free first synthesis of fully substituted phthalimides
    作者:Subhasis Samai、Debasish Ghosh、Uttam K. Das、Sanghamitra Atta、Saikat K. Manna、Dilip K. Maiti
    DOI:10.1039/c6gc00367b
    日期:——

    DMAP in water is exploited for a [2 + 2 + 2] and [3 + 2] cascade dual annulation for the first synthesis of fully-substituted phthalimides.

    中利用DMAP进行了[2 + 2 + 2]和[3 + 2]级联双环化反应,首次合成了全取代邻苯二甲酰亚胺
  • Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
    申请人:——
    公开号:US20030139431A1
    公开(公告)日:2003-07-24
    This invention provides compounds having the structure: 1 wherein X=CH, C(CH 3 ) or N; each of R 1 , R 2 , R 3 , R 4 and R 5 is independently H, C 1 -C 10 straight chained or branched alkyl, C 2 -C 10 straight chained or branched alkenyl, C 2 -C 10 straight chained or branched alkynyl, C 3 -C 10 cycloalkyl, substituted or unsubstituted aryl, hydroxy, halogenated ether, nitro, amino, halogen, —CN, —C(═Z)R 6 , —C(═Z)OR 6 , —C(═Z)N(R 6 ) 2 , —N(R 6 )—C(═Z)R 6 , —N(R 6 )—C(═Z)N(R 6 ) 2 , —OC(═Z)R 6 , —C(═Z)OR 6 —OR 6 or —SR 6 ; wherein Z is O or S; and wherein R 6 is C 1 -C 10 straight chained or branched alkyl, aryl, (CH 2 ) n Q, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 5 -C 10 cycloalkenyl, wherein Q is OR 7 , SR 7 , N(R 7 ) 2 or aryl, wherein R 7 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, wherein R 2 and R 3 and the carbons to which they are attached form a fused aryl, heteroaryl, C 5 -C 10 cyclic alkyl or heterocyclic alkyl ring; or wherein R 3 and R 4 and the carbons to which they are attached form a fused aryl, heteroaryl, cyclic alkyl or heterocyclic alkyl ring; and wherein each alkyl, alkenyl, alkynyl and alkoxy group is optionally substituted with a substituent independently selected from R a , where R a is 1) hydroxy, 2) C 1 -C 10 alkoxy, 3) halogen, 4) nitro, 5) amino, 6) CF 3 , or 7) carboxy, and each cycloalkyl group is optionally substituted with a substituent independently selected from R b , where R b is 1) a group selected from R a , 2) C 1 -C 7 alkyl, 3) C 2 -C 7 alkenyl, 4) C 2 -C 7 alkynyl or 5) cyclic C 1 -C 10 alkyl, and each aryl is optionally substituted with R 1 . This invention also provides methods of treating pain, urge incontinence; as well as methods of preparing the compounds.
    这项发明提供了具有以下结构的化合物:其中 X==CH,C(CH3)或N;R1、R2、R3、R4和R5中的每一个独立地是H、C1-C10直链或支链烷基、C2-C10直链或支链烯基、C2-C10直链或支链炔基、C3-C10环烷基、取代或未取代芳基、羟基、卤代醚、硝基、基、卤素、—CN、—C(═Z)R6、—C(═Z)OR6、—C(═Z)N(R6)2、—N(R6)—C(═Z)R6、—N(R6)—C(═Z)N(R6)2、—OC(═Z)R6、—C(═Z)OR6—OR6或—SR6;其中 Z 是 O 或 S;且其中 R6 是 C1-C10直链或支链烷基、芳基、(CH2)nQ、C2-C10烯基、C3-C10环烷基、C5-C10环烯基,其中 Q 是OR7、SR7、N(R7)2或芳基,其中 R7 是H、烷基、烯基、炔基、环烷基、环烯基、芳基,其中 R2、R3和它们连接的碳形成融合芳基、杂芳基、C5-C10环烷基或杂环烷基环;或其中 R3、R4和它们连接的碳形成融合芳基、杂芳基、环烷基或杂环烷基环;以及每个烷基、烯基、炔基和烷氧基组分可以选择性地取代一个从 Ra 中独立选择的取代基,其中 Ra 是 1) 羟基,2) C1-C10烷氧基,3) 卤素,4) 硝基,5) 基,6) CF3,或 7) 羧基,每个环烷基组分可以选择性地取代一个从 Rb 中独立选择的取代基,其中 Rb 是 1) 从 Ra 中选择的一组,2) C1-C7烷基,3) C2-C7烯基,4) C2-C7炔基或 5) 环状 C1-C10 烷基,每个芳基可以选择性地取代为 R1。这项发明还提供了治疗疼痛、尿急失禁的方法;以及制备这些化合物的方法。
  • Disazo pigment composition and printing ink
    申请人:DAINIPPON INK AND CHEMICALS, INC.
    公开号:EP0823459A2
    公开(公告)日:1998-02-11
    A disazo pigment composition, capable of being used to form inks or coatings having both high flow ability and high viscosity, containing (a) a disazo pigment, (b) an asymmetrical disazo compound having a water-soluble group and (c) an asymmetrical disazo compound, which has a substituent group possessing a hydrogen-bonding property.
    一种二氮杂颜料组合物,可用于配制具有高流动性和高粘度的油墨或涂料,该组合物包含 (a) 一种二氮杂颜料,(b) 一种具有溶性基团的不对称二氮杂化合物,以及 (c) 一种不对称二氮杂化合物,该化合物具有一个具有氢键特性的取代基团。
  • BORISEVICH, A. N.;ROMANENKO, E. A.;LOZINSKIJ, M. O.;SAMOJLENKO, L. S., YKP. XIM. ZH., 1984, 50, N 5, 525-529
    作者:BORISEVICH, A. N.、ROMANENKO, E. A.、LOZINSKIJ, M. O.、SAMOJLENKO, L. S.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫